BRPI0619214A2 - pró-fármacos de sulfonamidas heteroaromáticas - Google Patents

pró-fármacos de sulfonamidas heteroaromáticas Download PDF

Info

Publication number
BRPI0619214A2
BRPI0619214A2 BRPI0619214-9A BRPI0619214A BRPI0619214A2 BR PI0619214 A2 BRPI0619214 A2 BR PI0619214A2 BR PI0619214 A BRPI0619214 A BR PI0619214A BR PI0619214 A2 BRPI0619214 A2 BR PI0619214A2
Authority
BR
Brazil
Prior art keywords
quinine
carboxylate
trien
sulfamoyl
sulfamoylthiophene
Prior art date
Application number
BRPI0619214-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Ralf Wyrwa
Reinhard Nubbemeyer
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0619214A2 publication Critical patent/BRPI0619214A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0619214-9A 2005-11-30 2006-11-27 pró-fármacos de sulfonamidas heteroaromáticas BRPI0619214A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005057421A DE102005057421A1 (de) 2005-11-30 2005-11-30 Heteroaromatische Sulfonamid-Prodrugs
DE102005057421.1 2005-11-30
PCT/EP2006/011727 WO2007062875A1 (de) 2005-11-30 2006-11-27 Heteroaromatische sulfonamid-prodrugs

Publications (1)

Publication Number Publication Date
BRPI0619214A2 true BRPI0619214A2 (pt) 2011-09-20

Family

ID=37875507

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0619214-9A BRPI0619214A2 (pt) 2005-11-30 2006-11-27 pró-fármacos de sulfonamidas heteroaromáticas

Country Status (14)

Country Link
EP (1) EP1959964A1 (de)
JP (1) JP2009517425A (de)
KR (1) KR20080074197A (de)
CN (1) CN101321535A (de)
AU (1) AU2006319381A1 (de)
BR (1) BRPI0619214A2 (de)
CA (1) CA2632279A1 (de)
DE (1) DE102005057421A1 (de)
EA (1) EA200801209A1 (de)
EC (1) ECSP088488A (de)
IL (1) IL191563A0 (de)
NO (1) NO20082916L (de)
WO (1) WO2007062875A1 (de)
ZA (1) ZA200805660B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101987104A (zh) * 2009-08-05 2011-03-23 天津金耀集团有限公司 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物
CN101987102A (zh) * 2009-08-05 2011-03-23 天津金耀集团有限公司 一种糖皮质激素杂芳香基氨磺酰基羧酸酯的眼用抗炎组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593609A (en) * 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US6355666B1 (en) * 2000-06-23 2002-03-12 Medinox, Inc. Protected forms of pharmacologically active agents and uses therefor
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450

Also Published As

Publication number Publication date
DE102005057421A1 (de) 2007-05-31
CA2632279A1 (en) 2007-06-07
WO2007062875B1 (de) 2007-08-09
EA200801209A1 (ru) 2008-12-30
NO20082916L (no) 2008-06-27
WO2007062875A1 (de) 2007-06-07
JP2009517425A (ja) 2009-04-30
CN101321535A (zh) 2008-12-10
ECSP088488A (es) 2008-06-30
IL191563A0 (en) 2009-08-03
AU2006319381A1 (en) 2007-06-07
EP1959964A1 (de) 2008-08-27
ZA200805660B (en) 2009-11-25
KR20080074197A (ko) 2008-08-12

Similar Documents

Publication Publication Date Title
JP3541009B2 (ja) １９−ノルアンドロスタン系列の１４，１５−シクロプロパノステロイド、その製造法および該化合物を含有する製薬学的調製剤
CA1319362C (en) 4-substituted androstendione derivatives and process for their preparation
KR101687853B1 (ko) 17-히드록시-17-펜타플루오로에틸-에스트라-4,9(10)-디엔-11-아릴 유도체, 그의 제조 방법 및 질병 치료를 위한 그의 용도
US8492570B2 (en) 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action
JPH0242840B2 (de)
AU713341B2 (en) 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives
US4789668A (en) 1α,7α-dithio-substituted spirolactones, processes for their preparation, and their use as medicines
BRPI0619214A2 (pt) pró-fármacos de sulfonamidas heteroaromáticas
US20070135399A1 (en) Heteroaromatic sulphonamide prodrugs
CA2632272A1 (en) Sulfamoyl sulfonate prodrugs
US20070135375A1 (en) Sulfamoyl sulfonate prodrugs
NZ235944A (en) 4-(2-cyanimino-1,2-dihydro-pyridyl(and pyrimidyl))2,2-dimethyl chroman and pyrano(3,2-c)pyridine derivatives; preparatory processes and pharmaceutical compositiions
US20060154985A1 (en) Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates
NZ200779A (en) 4-alpha,5-alpha-epoxy-3,20-dioxopregnane-2-alpha
MX2008007039A (en) Heteroaromatic sulfonamide prodrugs
HU179980B (en) Process for preparing substituted steroid-spiro-oxazolidinone derivatives
NO174393B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-metyl-19-nor-pregna-4,6-diener som er 17 alpha-alkylert og eventuelt 21-alkylert
JP2003517001A (ja) 芳香族側鎖中にフルオロアルキル基を有する１１β−フェニルエストラジエン誘導体、その製造法および該化合物を含有する医薬組成物
ZA200007355B (en) Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same.
NO138147B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 15alfa,16alfa-methylen-4-pregnener
CA2516185A1 (en) Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates
JPH0212480B2 (de)
JPH02275870A (ja) １，４―チアジン誘導体

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]